Novel pain relief via marine snails.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The Lancet

• Publication date

  2005-08-06

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/S0140-6736(05)67040-7PMID 16084239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity: an overblown epidemic?

  2005cited by this paper
• Were arachnids the first to use combinatorial peptide libraries?

  2005cited by this paper
• Helix and Drugs: Snails for Western Health Care From Antiquity to the Present

  2005cited by this paper
• A toxin against pain.

  2005cited by this paper
• Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.

  2004cited by this paper
• How Much at Risk Are Cone Snails?

  2004cited by this paper
• Drugs from the sea: conopeptides as potential therapeutics.

  2004cited by this paper
• Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.

  2004cited by this paper
• Adverse effects associated with the intrathecal administration of ziconotide.

  2000cited by this paper
• Conus geographus envenomation.

  1997cited by this paper

• Phakellisins A-E, cyclopeptides from a marine sponge Phakellia sp. guided by LC-MS.

  2023cites this paper
• Application of marine natural products in drug research.

  2021cites this paper
• Analgesic and antipyretic natural products

  2020cites this paper
• TRANSLATIONAL RESEARCH SECTION Original Research Article Intravenous Injection of Leconotide, an Omega Conotoxin: Synergistic Antihyperalgesic Effects with Morphine in a Rat Model of Bone Cancer Pain

  2016cites this paper
• Human injuries and fatalities due to venomous marine snails of the family Conidae.

  2016cites this paper
• Intravenous injection of leconotide, an omega conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain.

  2011cites this paper
• Voltage-gated calcium channels and pain

  2010cites this paper
• CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain.

  2010cites this paper
• Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of act

  2009cites this paper
• Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke.

  2009cites this paper
• Biopharmaceuticals: Post‐Translational Modification Carboxylation and Hydroxylation

  2009cites this paper
• antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action

  2009cites this paper
• Advances in the development of novel analgesics

  2008cites this paper
• Nature's drug store attacks again: the cone snail's pain relief toxin

  2007cites this paper
• Marine-derived drugs in neurology.

  2007cites this paper
• New Conotoxin SO-3 Targeting N-type Voltage-Sensitive Calcium Channels

  2006cites this paper
• Marine Pharmacology in 2000: Marine Compounds with Antibacterial, Anticoagulant, Antifungal, Anti-inflammatory, Antimalarial, Antiplatelet, Antituberculosis, and Antiviral Activities; Affecting the Cardiovascular, Immune, and Nervous Systems and Other Miscellaneous Mechanisms of Action

  2003cites this paper